Claradele Pharmaceuticals
Greenville
About Claradele Pharmaceuticals
Claradele Pharmaceuticals is an early-stage biotechnology focused on developing effective and non-toxic cancer medicines. The firm was created to speed the development of a novel small-molecule medication class with both cytotoxic and immunostimulatory action.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $75.0K
- Last round: Grant (Sep 2022)
- Website: claradele.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/claradele-pharmaceuticals-179605 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.